Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: muller c. Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1. Intensive Care Med. 2022. PMID: 35106617 Free PMC article. Clinical Trial.
Monitoring of Apixaban in a Super Obese Patient.
Fietz C, Michels G, Müller C, Wiesen MHJ. Fietz C, et al. Among authors: muller c. Am J Med. 2019 Jan;132(1):e15-e16. doi: 10.1016/j.amjmed.2018.08.021. Epub 2018 Sep 7. Am J Med. 2019. PMID: 30201245 No abstract available.
Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.
Westermann I, Gastine S, Müller C, Rudolph W, Peters F, Bloos F, Pletz M, Hagel S. Westermann I, et al. Among authors: muller c. Br J Clin Pharmacol. 2021 Nov;87(11):4293-4303. doi: 10.1111/bcp.14846. Epub 2021 May 4. Br J Clin Pharmacol. 2021. PMID: 33818823 Free article.
Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand MA, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: muller c. Intensive Care Med. 2022 May;48(5):646-647. doi: 10.1007/s00134-022-06668-3. Intensive Care Med. 2022. PMID: 35303118 Free PMC article. No abstract available.
Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial.
Hünseler C, Balling G, Röhlig C, Blickheuser R, Trieschmann U, Lieser U, Dohna-Schwake C, Gebauer C, Möller O, Hering F, Hoehn T, Schubert S, Hentschel R, Huth RG, Müller A, Müller C, Wassmer G, Hahn M, Harnischmacher U, Behr J, Roth B; Clonidine Study Group. Hünseler C, et al. Among authors: muller a, muller c. Pediatr Crit Care Med. 2014 Jul;15(6):511-22. doi: 10.1097/PCC.0000000000000151. Pediatr Crit Care Med. 2014. PMID: 24751788 Clinical Trial.
The authors reply.
Hünseler C, Müller C, Roth B. Hünseler C, et al. Among authors: muller c. Pediatr Crit Care Med. 2015 Jan;16(1):93-4. doi: 10.1097/PCC.0000000000000294. Pediatr Crit Care Med. 2015. PMID: 25560291 No abstract available.
7,473 results